Pseudoephedrine hydrochloride; triprolidine hydrochloride - Generic Drug Details
What are the generic drug sources for pseudoephedrine hydrochloride; triprolidine hydrochloride and what is the scope of patent protection?
Pseudoephedrine hydrochloride; triprolidine hydrochloride
is the generic ingredient in twelve branded drugs marketed by Glaxosmithkline, Kv Pharm, Cenci, Usl Pharma, Newtron Pharms, Pvt Form, Chartwell Rx, Sandoz, Teva, Watson Labs, West Ward, Ivax Sub Teva Pharms, and Superpharm, and is included in sixteen NDAs. Additional information is available in the individual branded drug profile pages.Summary for pseudoephedrine hydrochloride; triprolidine hydrochloride
| US Patents: | 0 |
| Tradenames: | 12 |
| Applicants: | 13 |
| NDAs: | 16 |
| Patent Applications: | 33 |
| DailyMed Link: | pseudoephedrine hydrochloride; triprolidine hydrochloride at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for pseudoephedrine hydrochloride; triprolidine hydrochloride
US Patents and Regulatory Information for pseudoephedrine hydrochloride; triprolidine hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kv Pharm | TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 072758-001 | Nov 25, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Cenci | ACTAHIST | pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 088344-001 | Feb 9, 1984 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | CORPHED | pseudoephedrine hydrochloride; triprolidine hydrochloride | TABLET;ORAL | 088602-001 | Apr 11, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
